HOWL
Werewolf Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.98
+1.80%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.22
- Revenue estimate
- $18.3M
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- $0.08
- EPS estimate
- -$0.28
- Revenue actual
- $21.0M
- Revenue estimate
- $21.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +50.6%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | -$0.28 | $0.08 | Beat 128.57% | $21.0M |
| May 7, 2026 | -$0.32 | -$0.28 | Beat 12.50% | — |
| Mar 27, 2026 | -$0.34 | -$0.20 | Beat 41.18% | — |
| Aug 14, 2025 | -$0.50 | -$0.40 | Beat 20.00% | — |
| May 8, 2025 | -$0.44 | -$0.40 | Beat 9.09% | — |
| Mar 11, 2025 | -$0.43 | -$0.46 | Miss -6.98% | — |
| Nov 7, 2024 | -$0.41 | -$0.38 | Beat 7.32% | — |
| Aug 8, 2024 | -$0.38 | -$0.43 | Miss -13.16% | $1.1M |
| May 3, 2024 | -$0.35 | -$0.39 | Miss -11.43% | $742.0K |
| Mar 7, 2024 | -$0.43 | -$0.33 | Beat 23.26% | $1.5M |
| Nov 14, 2023 | -$0.27 | -$0.23 | Beat 14.81% | $5.9M |
| Aug 10, 2023 | -$0.41 | -$0.14 | Beat 65.85% | $8.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026